In situ β cell death promotes priming of diabetogenic CD8 T lymphocytes

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1466-1472

  Zhang, Yiqun ^a   O'Brien, Bronwyn ^a   Trudeau, Jacqueline ^a   Tan, Rusung ^a   Santamaria, Pere ^a   Dutz, Jan P ^a  

^a Skin Care Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD8 ANTIGEN; DNA; STREPTOZOCIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL DEATH; DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0036467353     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1466     Document Type: Article

References (64)

1. Insulin-dependent diabetes mellitus
2. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
3. + T cells
4. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice
5. + T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice
6. + T-cells from diabetic vs prediabetic NOD.NON-Thy-la donors
7. + T cells expressing identical endogenous TCR-α chains
8. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice
9. + cytotoxic T cells in the destruction of pancreatic β-cells in nonobese diabetic mice
10. 2m null mice are diabetes and insulitis resistant
11. 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes
12. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent
13. Major histocompatibility complex class I-restricted T cells are required for all but the endq stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement
14. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell Antigens in the pancreatic lymph nodes
15. Ontogeny of T cell tolerance to peripherally expressed antigens
16. Cross-presentation, dendritic cells, tolerance and immunity
17. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor Antigens
18. Cytotoxic T cell immunity to virus-infected non-hematopoietic cells requires presentation of exogenous antigen
19. Constitutive class I-restricted exogenous presentation of self antigens in vivo
20. Class I-restricted processing and presentation of exogenous cell-associated Antigen in vivo
21. 5 and Cd36 and cross-present antigens to cytotoxic T lymphocytes
22. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
23. Cutting edge: Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
24. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
25. Phenotypic analysis of antigen-specific T lymphocytes
26. β-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
27. + T cells from nonobese diabetic mice use highly homologous TCR α-chain CDR3 sequences
28. + T cell response against one peptide/MHC complex in autoimmune diabetes
29. MHC ligands and peptide motifs: First listing
30. Use of adoptive transfer of T cell-antigen-receptor-transgenic T cell for the study of T cell activation in vivo
31. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
32. Dynamics of β-cell mass in the growing rat pancreas: Estimation with a simple mathematical model
33. Neonatal β-cell apoptosis: A trigger for autoimmune diabetes?
34. Natural adjuvants: Endogenous activators of dendritic cells
35. Exact prediction of a natural T cell epitope
36. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus
37. Studies of streptozotocin-induced insulitis and diabetes
38. Immunologic studies on the induction of diabetes in experimental animals: Cellular basis for the induction of diabetes by streptozotocin
39. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic β cell line, INS-1
40. Relative importance of transport and alkylation for pancreatic β-cell toxicity of streptozotocin
41. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells
42. Mice lacking the poly(A)DP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozocin
43. Poly(A)DP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes
44. Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes
45. Early induction of diabetes in NOD mice by streptozotocin
46. + T cells
47. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens
48. Progression of autoimmune diabetes driven by avidity maturation of a T cell population
49. + T cell peripheral tolerance in nonobese diabetic mice
50. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
51. Systemic exposure to irradiated apoptotic cells induces autoantibody production
52. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway
53. + T-helper and a T-killer cell
54. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
55. Help for cytotoxic-T cell responses is mediated by CD40 signaling
56. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent
57. Major histocompatibility complex class I-restricted cross-presentation is biased toward high dose antigens and those released during cellular destruction
58. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity
59. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
60. Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE
61. Cutting edge: Amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(β-o-methyl)-fluoromethylketone
62. Update on major trials for the prevention of type 1 diabetes mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)
63. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing β-cell apoptosis
64. Prevention of cyclophosphamide-induced accelerated diabetes in the NOD mouse by nicotinamide or a soy protein-based infant formula